The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.

Lodi, S., Fisher, M., Phillips, A., De Luca, A., Ghosn, J., Malyuta, R., Zangerle, R., Moreno, S., Vanhems, P., Boufassa, F., Guiguet, M., Porter, K., Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection, <<PLOS ONE>>, 2013; 8 (11): e78642-e78642. [doi:10.1371/journal.pone.0078642] [http://hdl.handle.net/10807/54174]

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection

De Luca, Andrea;
2013

Abstract

The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.
2013
Inglese
Lodi, S., Fisher, M., Phillips, A., De Luca, A., Ghosn, J., Malyuta, R., Zangerle, R., Moreno, S., Vanhems, P., Boufassa, F., Guiguet, M., Porter, K., Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection, <<PLOS ONE>>, 2013; 8 (11): e78642-e78642. [doi:10.1371/journal.pone.0078642] [http://hdl.handle.net/10807/54174]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/54174
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 12
social impact